| | | |
M A1.1 Bioactive peptides applications identification | | | |
M A1.2 Successful definition of analytical methods and required equipment | | | |
M A1.3 Successful installation of the brewing facilities | | | |
| | | |
M D1.2 Dissemination and Communication plan | | | |
M B1.1 Successful adaptation and optimization of the process: production of different product strams with favourable nutrients properties | | | |
M B2.1 Successful demo-scale production of CYE and YCW with favourable nutrient properties | | | |
| | | |
M B4.1 Successful substitution of the commercial yeast extract by the CYE in industrial fermentations in the pharma industry | | | |
M C4.1 Animal feed study performed | | | |
M B3.1 Successful production of the beer with the CYE and YCW and successful sensory analysis | | | |
M B3.2 Replacement of high protein malt by normal malt + CYE without affecting organoleptic characteristics | | | |
| | | |
M C2.1 Socio-economic and market report | | | |
M C3.1 Technical plan for roll-out | | | |
M C3.2 Fine-tuned business plan | | | |
M C4.2 Contact with animal feed companies | | | |
M C4.3 Contact with companies from fermentation industry | | | |
M C4.4 Contact with food companies | | | |
M C4.5 Contact with wine companies | | | |
M C4.6 Contact with cosmetic industry | | | |
| | | |
M E2.1 At least 4 other EU funded projects contacted | | | |
M E4.1 After-LIFE plan finalized | | | |
M E3.1 Final report with project indicators | | | |